Bessemer Group’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82K Hold
12,873
﹤0.01% 1547
2025
Q4
$91K Buy
12,873
+12,265
+2,017% +$74K ﹤0.01% 1501
2025
Q3
$3K Sell
608
-277
-31% -$1.36K ﹤0.01% 2243
2025
Q2
$5K Hold
885
﹤0.01% 2028
2025
Q1
$6K Sell
885
-819
-48% -$6.23K ﹤0.01% 1958
2024
Q4
$13K Sell
1,704
-8,264
-83% -$59.3K ﹤0.01% 1656
2024
Q3
$70K Buy
9,968
+825
+9% +$4.96K ﹤0.01% 1331
2024
Q2
$45K Hold
9,143
﹤0.01% 1297
2024
Q1
$56K Buy
9,143
+2,768
+43% +$18.6K ﹤0.01% 1281
2023
Q4
$50K Buy
6,375
+1,179
+23% +$7.6K ﹤0.01% 1338
2023
Q3
$36K Buy
+5,196
New +$42.1K ﹤0.01% 1384

Other funds holding LFST

Bessemer Group's LFST Position: Q1 2026 in Review

Bessemer Group held its Lifestance Health (LFST) position steady in Q1 2026 at 12,873 shares worth $82K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Bessemer Group first reported a position in LFST in Q3 2023 and has held it in 11 quarters since. The position peaked at $91K in Q4 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Bessemer Group held 12,873 shares of Lifestance Health worth $82K as of Q1 2026.
  • Bessemer Group left its Lifestance Health share count unchanged in Q1 2026.
  • Lifestance Health made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #1547 holding.
  • Bessemer Group first reported a position in Lifestance Health in Q3 2023 and has held it in 11 quarters since.
  • Bessemer Group's Lifestance Health position peaked at $91K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.